Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX 153.25
-1.00 (-0.65%)
Jun 27, 2025, 4:35 PM BST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 7.04 million as of June 27, 2025. Its market cap has decreased by -60.82% in one year.
Market Cap
7.04M
Enterprise Value
9.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
153.25
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has decreased from 10.68M to 7.04M, a decrease of -34.09%. That is a compound annual growth rate of -5.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 157.30B |
| GSK plc | 56.46B |
| Haleon | 33.93B |
| Smith & Nephew | 9.63B |
| ConvaTec Group | 5.90B |
| Hikma Pharmaceuticals | 4.41B |
| HUTCHMED (China) | 1.89B |
| Oxford Nanopore Technologies | 1.30B |